Table 1.
Patient characteristics.
| Characteristics |
N (%) |
|
| Age (years) | ||
| <50 | 99(50.8) | |
| ≥50 | 96(49.2) | |
| Recurrent status | ||
| Yes | 71(36.4%) | |
| No | 117(60.0%) | |
| NA | 7 (3.6%) | |
| Living status | ||
| Yes | 153(78.5%) | |
| No | 35(17.9%) | |
| NA | 7 (3.6%) | |
| Tumor size (cm) | ||
| >5 | 8(4.1%) | |
| >2, ≤5 | 106(54.4%) | |
| ≤2 | 79(40.5%) | |
| NA | 2(1.0%) | |
| Histopathology | ||
| Invasive carcinoma of non-specific subtype | 177(90.8%) | |
| others | 18(9.2%) | |
| Mixed ductal and lobular carcinoma | 4 | |
| medullary carcinoma | 4 | |
| Mucinous carcinoma | 1 | |
| Invasive micropapillary carcinoma | 2 | |
| Invasive lobular carcinoma | 4 | |
| Metaplastic carcinoma(Adenosquamas carcinoma) | 1 | |
| Adjuvant chemotherapy | ||
| Yes | 135(69.2%) | |
| No | 29(14.9%) | |
| NA | 31(15.9%) | |
| Adjuvant radiotherapy | ||
| Yes | 33(16.9%) | |
| No | 142(72.8%) | |
| NA | 20(10.3%) | |
| Basal-like subtype | ||
| Yes | 152(77.9%) | |
| No | 43(22.1%) | |
| Grade | ||
| Grade1 | 9(7.9%) | |
| Grade2 | 52(30.7%) | |
| Grade3 | 134(61.4%) | |
| P53 | Positive | 93(47.7%) |
| Negative | 101(51.8%) | |
| NA | 1(0.5%) | |
| Ki67 | ||
| <20% | 35(17.9%) | |
| ≥20% | 160(82.1%) | |
| TILs amount | <30% | 143(73.3%) |
| ≥30% | 49(25.1%) | |
| NA | 3(1.5%) | |
| TILs PD1 protein | Positive | 128(65.6%) |
| Negative | 54(27.7%) | |
| NA | 13(6.7%) | |
| Tumor cells PDL1 protein | Positive | 13(6.7%) |
| TILs PDL1 protein | Negative | 182(93.3) |
| Positive | 61(31.3%) | |
| Negative | 134(68.7%) | |
| Pathological stage | ||
| I | 50(25.7%) | |
| II | 105(53.8%) | |
| III | 40(20.5%) | |
| Lymphonodes metastasis | ||
| Yes | 82(42.1%) | |
| No | 106(54.4%) | |
| NA | 7(3.5%) | |
| Distant metastasis | ||
| Yes | 57(29.2%) | |
| No | 131(67.2%) | |
| NA | 7(3.6%) | |
| Death | ||
| Yes | 35(17.9%) | |
| No | 153(78.5%) | |
| NA | 7(3.6%) | |